SKI Market

Indian Indices

Sensex

79,884.40 768.21
( 0.97%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.96 0.48
(0.52%)

EUR-INR

106.94 -0.34
(-0.32%)

GBP-INR

122.70 0.09
(0.07%)

JPY-INR

0.58 0.00
(0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524412

INE198H01019

51.1335451

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAREYDRUGS

56.66

194.4

EPS(TTM)

Face Value()

Div & Yield %

1.21

Back

Procter & Gamble Health standalone net profit rises 7.54% in the September 2025 quarter

Nov 05,2025

Net profit of Procter & Gamble Health rose 7.54% to Rs 88.54 crore in the quarter ended September 2025 as against Rs 82.33 crore during the previous quarter ended September 2024. Sales rose 3.67% to Rs 324.92 crore in the quarter ended September 2025 as against Rs 313.41 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	324.92	313.41	4
OPM %	37.02	36.39	-
PBDT	125.10	117.17	7
PBT	119.02	111.40	7
NP	88.54	82.33	8

79,884.40 768.21 ( 0.97%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

55,141.42 895.88 (1.65%)

10,568.52 84.39 (0.80%)

91.96 0.48 (0.52%)

106.94 -0.34 (-0.32%)

122.70 0.09 (0.07%)

0.58 0.00 (0.18%)